Breaking News

Pace Life Sciences Acquires Biopharma Global

Acquisition extends Pace’s reach further into regulatory strategy, guidance, and support in key therapeutic areas.

Author Image

By: Charlie Sternberg

Associate Editor

Pace Life Sciences LLC, a full-service contract development and manufacturing organization (CDMO) and a subsidiary of Pace, a science and technology company, has acquired Biopharma Global (Biopharma), which specializes in full-service regulatory support for orphan products to treat rare diseases and non-orphan products to treat indications with unmet medical needs.   “Pace provides great value in our marketplace through our technical expertise and by meeting the strong commitments we mak...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters